Spotlight

UCL cancer immunotherapy company, Autolus, launches with £30m investment

A new UCL spin-out company – Autolus – is being launched today to develop and commercialise a new generation of engineered T-cell therapies for haematological and solid tumours, with the backing of £30m in investment from healthcare investment company Syncona.

Find out more



follow us on twitter


Camden Business Awards - Young Entrepreneur of the Year

11 September 2013

This award is open to all Camden based business owners aged 30 years or younger who have launched their business in the last 3 years and can demonstrate one or more of the following criteria

  • Exceptional business acumen
  • Innovation in terms of products or ways of working
  • Consistent business growth

Deadline: 1 October 2013

Find out more about the Camden Business Awards